These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26172202)

  • 1. To eliminate tuberculosis, we must universally encourage treatment of its latent form.
    Schraufnagel DE
    Respirology; 2015 Aug; 20(6):851-4. PubMed ID: 26172202
    [No Abstract]   [Full Text] [Related]  

  • 2. To eliminate tuberculosis, we must universally encourage treatment of its latent form.
    Konstantinos A
    Respirology; 2016 Feb; 21(2):396. PubMed ID: 26573760
    [No Abstract]   [Full Text] [Related]  

  • 3. To eliminate tuberculosis, we must universally encourage treatment of its latent form - Reply.
    Schraufnagel DE
    Respirology; 2016 Feb; 21(2):396-7. PubMed ID: 26573743
    [No Abstract]   [Full Text] [Related]  

  • 4. It is time to deal with latent tuberculosis infection in Taiwan.
    Chan PC; Huang LM; Suo J
    J Formos Med Assoc; 2009 Dec; 108(12):901-3. PubMed ID: 20040453
    [No Abstract]   [Full Text] [Related]  

  • 5. Detect to Prevent: Evaluating Testing and Treatment Practices for Latent Tuberculosis Infection in Long-Term Care Facilities.
    Winston CA; Stone ND
    J Am Geriatr Soc; 2017 Jun; 65(6):1139-1140. PubMed ID: 28306136
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.
    Reves R; Daley CL
    JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130
    [No Abstract]   [Full Text] [Related]  

  • 7. Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies.
    Druszczyńska M; Kowalewicz-Kulbat M; Fol M; Włodarczyk M; Rudnicka W
    Pol J Microbiol; 2012; 61(1):3-10. PubMed ID: 22708341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contact tracing and prophylaxis of tuberculosis].
    Seersholm N; Wilcke T
    Ugeskr Laeger; 2011 Mar; 173(12):883-6. PubMed ID: 21419057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating between latent and active tuberculosis: the role of interleukin-2 as biomarker.
    Mamishi S; Pourakbari B; Marjani M; Bahador A; Mahmoudi S
    J Infect; 2015 Apr; 70(4):429-31. PubMed ID: 25562449
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.
    Chee CB; Sester M; Zhang W; Lange C
    Respirology; 2013 Feb; 18(2):205-16. PubMed ID: 23107218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National position statement for the management of latent tuberculosis infection.
    Stock D;
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent tuberculosis.
    Am Fam Physician; 2014 Jun; 89(11):Online. PubMed ID: 25077404
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges in diagnosis and treatment of latent tuberculosis infection.
    Gupta KB
    Indian J Tuberc; 2012 Jan; 59(1):1-5. PubMed ID: 22670504
    [No Abstract]   [Full Text] [Related]  

  • 14. [Latent tuberculosis infection sreening and preventive therapy in students].
    Chen W; Cheng S
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):21-4. PubMed ID: 27264574
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis and Treatment of Latent Tuberculosis Infection.
    Chitnis AS; Jaganath D; Gish RG; Wong RJ
    Am J Gastroenterol; 2021 Nov; 116(11):2155-2158. PubMed ID: 34382949
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of secondary tuberculosis in the contact tracing].
    Matsumoto K; Shimouchi A
    Kekkaku; 2011 Nov; 86(11):889-90. PubMed ID: 22295434
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary guidelines of the Brazilian Society of Rheumatology for evaluation and treatment of tuberculosis latent infection in patients with rheumatoid arthritis, in face of unavailability of the tuberculin skin test].
    da Mota LM; Cruz BA; de Albuquerque CP; Gonçalves D; Laurindo IM; Pereira IA; de Carvalho JF; Pinheiro Gda R; Bertolo MB; da Silva NA; Louzada Júnior P; Xavier RM; Giorgi RD; Lima RA
    Rev Bras Reumatol; 2015; 55(4):390-3. PubMed ID: 26165801
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence, screening and treatment of latent tuberculosis among oral corticosteroid recipients.
    Vozoris NT; Seemangal J; Batt J
    Eur Respir J; 2014 Nov; 44(5):1373-5. PubMed ID: 24969656
    [No Abstract]   [Full Text] [Related]  

  • 19. From latent to patent: rethinking prediction of tuberculosis.
    Cobelens F; Kik S; Esmail H; Cirillo DM; Lienhardt C; Matteelli A
    Lancet Respir Med; 2017 Apr; 5(4):243-244. PubMed ID: 28017341
    [No Abstract]   [Full Text] [Related]  

  • 20. Practice guideline for treatment of latent tuberculosis infection in children.
    Nicholson EG; Geltemeyer AM; Smith KC
    J Pediatr Health Care; 2015; 29(3):302-7. PubMed ID: 25792195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.